Advertisement

Topics

Minerva Neurosciences, Inc.: Minerva Neurosciences Announces Pricing of Public Offering of Common Stock

18:52 EDT 28 Jun 2017 | FinanzNachrichten

WALTHAM, Mass., 2017-06-29 00:45 CEST (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company, today announced the pricing of an underwritten publi...

Original Article: Minerva Neurosciences, Inc.: Minerva Neurosciences Announces Pricing of Public Offering of Common Stock

NEXT ARTICLE

More From BioPortfolio on "Minerva Neurosciences, Inc.: Minerva Neurosciences Announces Pricing of Public Offering of Common Stock"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...